OUP Management as of June 30, 2023
Portfolio Holdings for OUP Management
OUP Management holds 12 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Centessa Pharmaceuticals Sponsored ADS (CNTA) | 31.0 | $18M | 2.9M | 6.19 | |
| DICE Therapeutics Common Stock | 21.3 | $13M | 268k | 46.46 | |
| Aerovate Therapeutics Common Stock (AVTE) | 17.7 | $10M | 604k | 17.15 | |
| Cyteir Therapeutics Common Stock | 10.9 | $6.4M | 2.5M | 2.60 | |
| PMV Pharmaceuticals Common Stock (PMVP) | 10.6 | $6.2M | 989k | 6.26 | |
| Vor Biopharma Common Stock (VOR) | 2.0 | $1.2M | 375k | 3.09 | |
| Graphite Bio Common Stock | 1.8 | $1.1M | 406k | 2.60 | |
| Selecta Biosciences Common Stock (RNAC) | 1.6 | $966k | 863k | 1.12 | |
| eFFECTOR Therapeutics Common Stock | 1.5 | $852k | 1.0M | 0.83 | |
| Precision BioSciences Common Stock | 1.0 | $591k | 1.1M | 0.53 | |
| Spero Therapeutics Common Stock (SPRO) | 0.6 | $361k | 249k | 1.45 | |
| Homology Medicines Common Stock | 0.1 | $57k | 64k | 0.89 |
